On the evening of September 13, Star Lake Technology issued an announcement on the resolution of the second extraordinary shareholders meeting in 2023, electing the company’s new board of directors. Liu Libin, Chen Wu, Ying Jun, Yan Xiaolin, Yan Xiaolong, and Li Yongsheng were elected. Directors, Wang Yan, Liu Yanqing and Liu Heng were elected as independent directors.
Xinghu Technology also issued a board meeting resolution announcement, electing Liu Libin as the chairman of the company’s 11th board of directors, agreeing to appoint Ying Jun as the company’s general manager, appointing Yan Xiaolin, Yan Xiaolong, Huang Lijian, and Zhang Fanping as the company’s deputy general managers, and appointing Chen Junlai as the company’s deputy general manager. The company’s financial director appointed Zhang Kaijia as secretary of the company’s board of directors.
Integration and collaboration continue to deepen and business competitiveness continues to be enhanced
Data show that Xinghu Technology is a high-tech manufacturing enterprise with biological fermentation and chemical synthesis as its core. It is the only listing platform for the biotechnology and food main business sectors of Guangxin Group, a state-owned enterprise in Guangdong Province. In November 2022, Xinghu Technology completed the reorganization of Yipin Biotech by issuing shares and paying cash, which significantly increased the company’s asset size and business scale, further enriched its product categories, and achieved leapfrog development.
After the merger is completed, the company will focus on accelerating business integration and company integration, establish an integration development working group, and designate 2023 as the “Integration Development Year” to integrate internal and external resources of the company and carry out integration work in a coordinated and orderly manner. At the same time, McKinsey & Company, a leading international strategic consulting firm, was hired to provide consulting services in aspects such as strategic development, headquarters functions, organizational structure, and system construction to better guide and promote integration.
Capital market experts believe that among the new members of the board of directors elected this time, on the basis of the current senior managers of listed companies, there will be new executives from the major shareholder Guangxin Group, as well as executives from the important subsidiary Yipin Biotechnology , will help accelerate the integration of the team, give full play to the strength of Guangxin Group as a Fortune 500 company and the advantages of Yipin Biotech as the leader in the subdivided industry, and promote the listed company to accelerate its progress towards the leading enterprise and industry leader in the synthetic biology industry.
Amino acid prices are rising and the industry is expected to pick up
After the acquisition of Yipin Bio, Xinghu Technology has become a leading company in the global animal amino acid industry and food additive industry. Among its main products, lysine production capacity ranks second in the world, threonine production capacity ranks third in the world, and MSG production capacity ranks third in the world. Four,
I+G’s production capacity ranks second in the country.
Against the background of steady growth in demand from the downstream feed and breeding industries and consumption upgrading, the animal nutritional amino acid and MSG industries have room for sustainable development and further release of profits.
From a price point of view, amino acid prices are gradually recovering. Since June, the prices of the main products of listed companies represented by lysine and threonine have shown obvious signs of “heading upward”. Among them, the price of threonine products has risen to Close to the high point in 2022, lysine prices have gradually stabilized and rebounded.
Industry insiders pointed out that the reasons for the rebound in amino acid prices are domestic: first, the downstream demand for major amino acid products of large varieties continues to improve, the prices of livestock, poultry, and egg products are gradually rising, market purchases and sales are active, and amino acid prices are improving; second, The reason is that the release of new production capacity in the industry is relatively limited in the short term; third, the market’s bullish expectations for soybean meal prices have increased downstream manufacturers’ demand for amino acids and corn by-products; from the perspective of overseas factors, the early excess purchase stocks in the European and American markets have been basically consumed It has returned to normal levels. At the same time, Russia’s largest lysine factory temporarily suspended production in June, which will become an important support for the continued rise in international amino acid product prices and the recovery of industry income.
Overall, the main adverse factors affecting the industry’s cyclical downward trend since 2022 have been effectively alleviated, and the cyclicality has bottomed out. Companies in the industry are expected to further release profit margins in the second half of 2023.
Bio-based materials are gradually rising in popularity and are expected to become a new growth point for business
In recent years, under the background of the “dual carbon” policy, many domestic companies have begun to increase research and investment in the field of bio-based nylon. Yipin Biotechnology has taken the lead and is currently one of the very few companies in China that has mastered the core technologies of bio-based pentanediamine and bio-based nylon 56 new material products, and has built a relatively complete technology patent protection system.
According to reports, the Elon series nylon products developed by Yipin Biotechnology have obtained the United States Department of Agriculture (USDA) bio-based product label certification. The bio-based carbon content reaches 48%, the carbon reduction effect is obvious, and the technology is in the leading position in the industry.
At present, the company has deployed new material products such as pentanediamine and bio-based nylon 56 in its Heilongjiang production base. It has built a 10,000-ton pentanediamine and 20,000-ton nylon 56 salt production line, and is building a 10,000-ton nylon 56 chip production line. It is expected to be put into production by the end of this year and has the ability to quickly expand production scale.
Looking forward to the future, Star Lake Technology will take synthetic biology technology as the core and biological fermentation as the foundation. It will continue to vigorously explore diversified product structures, enrich downstream application scenarios, continue to increase the company’s output value and profit levels, and strive to become a leader in the synthetic biology industry. Leading companies and industry leaders.
微信扫一扫打赏
